A legume-enriched diet improves metabolic health in prediabetes mediated through gut microbiome: a randomized controlled trialOriginal paper
Karen Pendergrass is a microbiome researcher specializing in microbiome-targeted interventions (MBTIs). She systematically analyzes scientific literature to identify microbial patterns, develop hypotheses, and validate interventions. As the founder of the Microbiome Signatures Database, she bridges microbiome research with clinical practice. In 2012, based on her own investigative research, she became the first documented case of FMT for Celiac Disease, four years before the first published case study.
Read MoreWhat was studied?
This study examined whether adding a legume-enriched, multicomponent diet to a calorie-restricted eating plan could improve metabolic health beyond calorie restriction alone. It was designed as a 16-week, single-blind, parallel-group randomized controlled trial comparing an intervention diet against a calorie-restricted control diet. The primary outcomes tracked were markers of glycemia, with measurements taken at two- or four-week intervals throughout the trial. The researchers also examined whether gut microbiome changes, particularly shifts in fiber-degrading species and related metabolites, mediated any observed benefits.
Who was studied?
The trial enrolled 127 Chinese participants with prediabetes living in Singapore, randomized into an intervention group (n = 63) and a control group (n = 64). Participants had a mean age of 62.2 years and a mean BMI of 23.8 kg/m2, indicating an older adult population that was not obese by standard classification. Both groups received calorie-restricted diets, with the intervention group's diet additionally enriched with legumes as part of a multicomponent approach.
What were the most important findings?
Both groups significantly reduced their BMI after 16 weeks compared with baseline, with minimal difference between the two diets on this measure. However, the legume-enriched intervention group showed significantly greater reductions in LDL cholesterol, total cholesterol, and HbA1c compared with the calorie-restricted control group. These improvements were accompanied by increases in fiber-degrading bacterial species in the intervention group, with the effects appearing to be mediated through metabolites such as bile acids and amino acids.
What are the greatest implications of this study?
The findings suggest that enriching a calorie-restricted diet with legumes provides added metabolic benefits for people with prediabetes beyond calorie restriction alone, particularly for lipid and glycemic markers. The mediating role of fiber-degrading gut bacteria and metabolites like bile acids and amino acids points to the gut microbiome as a mechanistic link between legume intake and improved metabolic outcomes. This supports legume-enriched dietary patterns as a practical, food-based strategy for managing prediabetes, with the gut microbiome as a potential target for further intervention research.